Vaccinia virus protein A3 is required for the production of normal immature virions and for the encapsidation of the nucleocapsid protein L4

Virology
Desyree Murta JesusRichard C Condit

Abstract

Maturation of the vaccinia virion is an intricate process that results in the organization of the viroplasm contained in immature virions into the lateral bodies, core wall and nucleocapsid observed in the mature particles. It is unclear how this organization takes place and studies with mutants are indispensable in understanding this process. By characterizing an inducible mutant in the A3L gene, we revealed that A3, an inner core wall protein, is important for formation of normal immature viruses and also for the correct localization of L4, a nucleocapsid protein. L4 did not accumulate in the viral factories in the absence of A3 and was not encapsidated in the particles that do not contain A3. These data strengthen our previously suggested hypothesis that A3 and L4 interact and that this interaction is critical for proper formation of the core wall and nucleocapsid.

References

Feb 15, 1991·Proceedings of the National Academy of Sciences of the United States of America·Y F Zhang, B Moss
Jul 1, 1970·Proceedings of the National Academy of Sciences of the United States of America·E Katz, B Moss
Jul 18, 1995·Proceedings of the National Academy of Sciences of the United States of America·G A WardT R Fuerst
Oct 14, 2000·The Journal of Biological Chemistry·G AndrésM L Salas
Nov 20, 2002·Journal of Virology·Germán AndrésMaría L Salas
Oct 1, 1963·Virology·D PETERS, G MUELLER
May 28, 2004·Journal of Virology·Camilo Ansarah-Sobrinho, Bernard Moss
May 14, 2005·Journal of Virology·Jason Mercer, Paula Traktman
Sep 5, 2012·Virology·Baron D H McFaddenRichard C Condit
Mar 26, 2014·Molecular and Cellular Biology·Daniel K RozelleJohn H Connor

❮ Previous
Next ❯

Citations

Jan 14, 2016·ACS Nano·Steven M ScherrM Selim Ünlu
May 8, 2016·Journal of Structural Biology·Desyree Murta JesusRichard C Condit
Jan 8, 2019·PLoS Pathogens·Yeva Mirzakhanyan, Paul Gershon
Apr 3, 2020·PloS One·Caitlin M O'ConnellPaulo H Verardi

❮ Previous
Next ❯

Related Concepts

Related Feeds

Aminoglycosides

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.

Aminoglycosides (ASM)

Aminoglycoside is a medicinal and bacteriologic category of traditional Gram-negative antibacterial medications that inhibit protein synthesis and contain as a portion of the molecule an amino-modified glycoside. Discover the latest research on aminoglycoside here.